NPI: 1558392977 · DURHAM, NC 27710 · Internal Medicine Physician · NPI assigned 07/05/2006
Authorized official SMITH, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | SMITH, JOHN (VP, FINANCE) |
| Parent Organization | DUKE UNIVERSITY HEALTH SYSTEM, INC |
| NPI Enumeration Date | 07/05/2006 |
Other providers sharing the same authorized official: SMITH, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 601 | $25K |
| 2019 | 857 | $47K |
| 2020 | 412 | $17K |
| 2021 | 1,574 | $43K |
| 2022 | 1,047 | $51K |
| 2023 | 1,094 | $38K |
| 2024 | 2,008 | $67K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1,368 | 1,236 | $83K |
| 97750 | 1,984 | 1,415 | $57K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 329 | 192 | $28K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1,230 | 589 | $17K |
| 97164 | 387 | 292 | $12K | |
| 99460 | 168 | 160 | $12K | |
| J0248 | Injection, remdesivir, 1 mg | 47 | 16 | $11K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 31 | 26 | $9K |
| 99238 | Hospital discharge day management, 30 minutes or less | 151 | 147 | $9K |
| 90791 | Psychiatric diagnostic evaluation | 81 | 77 | $8K |
| 01920 | 37 | 36 | $5K | |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | 26 | 13 | $5K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 222 | 95 | $5K |
| 90832 | Psychotherapy, 30 minutes with patient | 169 | 97 | $4K |
| 00140 | 55 | 50 | $4K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 206 | 141 | $3K |
| 99215 | Prolong outpt/office vis | 59 | 54 | $3K |
| 99462 | 75 | 67 | $2K | |
| 97597 | 194 | 139 | $2K | |
| 99253 | 19 | 15 | $2K | |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | 61 | 44 | $1K |
| 99443 | 59 | 42 | $1K | |
| 99221 | 26 | 24 | $1K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 44 | 16 | $1K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 81 | 68 | $961.80 |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | 25 | 12 | $940.06 |
| 97161 | 21 | 12 | $828.04 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 39 | 39 | $456.29 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 360 | 283 | $353.03 |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 22 | 13 | $259.05 |
| 99442 | 17 | 13 | $93.84 |